CD38 and neoplasm: This was inturn validated molecularly with CD38 IHC, where, in comparison to diffuse strongmembranous positivity of CD38 in all marrow cells of the vehicle tumor tissue,there was near total absence of CD38 in any remnant cells in theAU-24118-treated orthotopic xenografts.